This article is more than 5 years old. Information may no longer be current.

FDA grants clearance to Ceterix for meniscal repair system

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Ceterix Orthopedics has received 510(k) clearance from the FDA for its NovoStitch Plus meniscal repair system.

According to a company press release, the meniscal repair system allows for placement of a circumferential compression stitch around the meniscus to generate uniform compression during healing and allow orthopedic surgeons to treat complex injuries. The device also uses a pre-loaded suture implant to improve ease of use and reduce the number of procedure steps by more than half.

“We believe the usability improvements in this new device will enable surgeons to provide meniscus repair to an even broader set of patients who need better solutions for this common knee injury,” John McCutcheon, president and CEO of Ceterix Orthopaedics, stated in the release.   

Reference: www.ceterix.com